Home/Filings/4/0001013606-20-000006
4//SEC Filing

Thompson Matthew 4

Accession 0001013606-20-000006

CIK 0001013606other

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 4:20 PM ET

Size

6.5 KB

Accession

0001013606-20-000006

Insider Transaction Report

Form 4
Period: 2019-12-30
Thompson Matthew
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2019-12-30+47,01184,244 total
  • Tax Payment

    Common Stock

    2019-12-30$1.68/sh5,278$8,86778,966 total
Footnotes (2)
  • [F1]This award was originally reported on a Form 4 filed with the Securities and Exchange Commission on January 2, 2019. One third of the shares subject to this restricted stock unit award vested pursuant to the terms of this award.
  • [F2]Shares withheld on December 30, 2019 to satisfy statutory minimum tax withholding obligations related to shares vested on December 30, 2019.

Issuer

ENDOLOGIX INC /DE/

CIK 0001013606

Entity typeother

Related Parties

1
  • filerCIK 0001740988

Filing Metadata

Form type
4
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 4:20 PM ET
Size
6.5 KB